Invention Grant
- Patent Title: MCL1 inhibitors
-
Application No.: US17094447Application Date: 2020-11-10
-
Publication No.: US11667652B2Publication Date: 2023-06-06
- Inventor: Hang Chu , Juan A. Guerrero , Anna E. Hurtley , Lan Jiang , Darryl Kato , Tetsuya Kobayashi , David W. Lin , Jonathan William Medley , Devan Naduthambi , Vickie H. Tsui , Chandrasekar Venkataramani , William J. Watkins , Hong Yang , QingMing Zhu
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Main IPC: C07D513/08
- IPC: C07D513/08 ; C07D513/10 ; C07D513/20 ; C07D513/22 ; A61K31/553 ; A61P35/00 ; C07D513/18 ; A61K45/06 ; C07D519/00 ; C07K16/28
Abstract:
The present disclosure generally relates to compounds of Formula (I) and pharmaceutical compositions that may be used in methods of treating cancer.
Public/Granted literature
- US20210171543A1 MCL1 INHIBITORS Public/Granted day:2021-06-10
Information query
